ELS - Draft Pricing Tables.xlsx
XLSX spreadsheet 27 KB Posted
- Attached to
- Polymerase Chain Reaction (PCR) COVID-19 Testing Support Federal contract opportunity
- Solicitation number
- 19AQMM20R0309
About this file
This notice provides information on an upcoming solicitation for Polymerase Chain Reaction (PCR) COVID-19 testing support services. The U.S. Department of State Bureau of Medical Services requires a CLIA-certified laboratory to support on-site and off-premises specimen collection and processing for laboratory tests in the National Capital Region. Services will include on-site biological specimen collection and transportation, as well as reverse transcriptase PCR testing for SARS-CoV-2 virus including collection of specimens. The anticipated one-year base period and four one-year option periods, plus a six-month extension, will utilize firm-fixed-price and firm-fixed-unit-price contract line items. The 100% small business set-aside solicitation is expected to be released between August 24-28, utilizing best value tradeoff evaluation. Technical merit is more important than price. The notice provides draft pricing tables and requests relevant experience from potential offerors.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| ELS - Draft Relevant Experience Questionnaire.docx | DOCX document | |
| ELS - Draft Performance Work Statement.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
1. NTE Profit Percentages Pricing Table 1
Proposed Not-to-Exceed (NTE) Profit Percentages
| Proposed Not-to-Exceed (NTE) Profit Percentages | ||||||
| Base Period | Option Year 1 | Option Year 2 | Option Year 3 | Option Year 4 | Option Year 5 | Six-Month Option to Extend |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Notes | ||||||
| 1) Offerors shall propose one profit percentage per contract year | ||||||
| 2) The proposed profit percentages shall not exceed two decimal places |
2. IDIQ Prices Pricing Table 2 Enhanced Laboratory Support Services
CLIN Description Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4 Six-Month Option (FAR 52.217-8) Total
| NTE Price per Task Order, per day | Quantity | Subtotal | NTE Price per Task Order, per day | Quantity | Subtotal | NTE Price per Task Order, per day | Quantity | Subtotal | NTE Price per Task Order, per day | Quantity | Subtotal | NTE Price per Task Order, per day | Quantity | Subtotal | NTE Price per Task Order, per day | Quantity | Subtotal | ||
| X001 | On-Site Biological Specimen Collection (2401 E St NW |
Washington DC) biological specimen collection and transportation of specimens to the Contractor's processing location for 180 personnel being tested (includes all labor costs, other direct costs, applicable indirect costs, profit/fee) 365 - 365 - 365 - 365 - 365 - 183 - -
| NTE Price per Test | Quantity | Subtotal | NTE Price per Applicant | Quantity | Subtotal | NTE Price per Applicant | Quantity | Subtotal | NTE Price per Applicant | Quantity | Subtotal | NTE Price per Applicant | Quantity | Subtotal | NTE Price per Applicant | Quantity | Subtotal | ||
| X0002 | Reverse Transcriptase PCR Testing for SARS-CoV-2 Virus. |
Includes collection of necessary biological specimens at the Contractor's processing location (includes all labor costs, other direct costs, applicable indirect costs, profit/fee) 131,400 - 131,400 - 131,400 - 131,400 - 131,400 - 65,700 - -
Total - - - - - -
OVERALL PROPOSED PRICE -
| Notes: |
| 1) Offerors shall propose one not-to-exceed (NTE) unit price per contract period for each CLIN |
| 2) Offerors shall not alter the Excel sheet in any way other than to fill out the yellow-highlighted areas |
| 3) Quantity (CLIN X001) = RFP-specified estimated number of days that on-site biological specimen collection will occur |
| 4) Quantity (CLIN X0002) = RFP-specified estimated number of Reverse Transcriptase PCR tests for SARS-CoV-2 virus |
File details come from the government source that posted it. Updated .